Discover Danaher's strong Q3 results, strategic reinvestments, and biotech growth. See why DHR is poised for future earnings ...
It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. | It is financial ...
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q3 CY2025, with ...
"Cepheids don't pulse at the same rate, but rather at a rate proportional to their brightness, which means that from an ...
Danaher Corp (DHR) reports robust Q3 performance with $6.1 billion in sales, a 10% increase in adjusted EPS, and a $2 billion ...
Cells at the bottom of a liquid medium begin levitating, then hovering at a particular height. With no physical contact, an ...
Shenzhen SiCarrier Technologies, a fast-rising semiconductor equipment firm closely linked to Huawei, is once again making ...
While quantum phenomena can be demonstrated using experiments such as the Double-Slit Experiment, certifying that a ...
Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s ...
But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...
The expansion of the HSV testing market is being fueled by a combination of increasing prevalence of HSV infections, ...